rs781136336
Variant summary
Our verdict is Uncertain significance. Variant got 5 ACMG points: 5P and 0B. PM2PP3_ModeratePP5
The NM_000203.5(IDUA):āc.1577T>Cā(p.Leu526Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000391 in 1,522,386 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_000203.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 5 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
IDUA | NM_000203.5 | c.1577T>C | p.Leu526Pro | missense_variant | 11/14 | ENST00000514224.2 | NP_000194.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
IDUA | ENST00000514224.2 | c.1577T>C | p.Leu526Pro | missense_variant | 11/14 | 2 | NM_000203.5 | ENSP00000425081 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000270 AC: 41AN: 151922Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000336 AC: 40AN: 118962Hom.: 0 AF XY: 0.000397 AC XY: 26AN XY: 65432
GnomAD4 exome AF: 0.000404 AC: 554AN: 1370464Hom.: 0 Cov.: 33 AF XY: 0.000413 AC XY: 279AN XY: 676024
GnomAD4 genome AF: 0.000270 AC: 41AN: 151922Hom.: 0 Cov.: 33 AF XY: 0.000337 AC XY: 25AN XY: 74204
ClinVar
Submissions by phenotype
Mucopolysaccharidosis type 1 Pathogenic:2
Likely pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Aug 20, 2024 | Variant summary: IDUA c.1577T>C (p.Leu526Pro) results in a non-conservative amino acid change in the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 0.00034 in 118962 control chromosomes. This frequency is not significantly higher than estimated for a pathogenic variant in IDUA causing Mucopolysaccharidosis Type 1 (0.00034 vs 0.0027), allowing no conclusion about variant significance. c.1577T>C has been reported in the literature in newborn screening studies (e.g. Donati_2018, Wasserstein_2019, Polo_2020, Bosfield_2021). One newborn in particular was found to be homozygous for this variant and exhibited urinary and dried blood spot glycosaminoglycan (GAG) levels within normal range (Donati_2018, Polo_2020). However, no follow-up data from a later stage of life were available to determine the actual phenotype. In contrast, a second homozygous individual was reported who had a clinical diagnosis of Mucopolysaccharidosis Type 1 with an attenuated phenotype (Zhang_2022). Importantly, the variant was also detected in combination with other known pathogenic variants in individuals affected with Mucopolysaccharidosis Type 1 (Pollard_2013, Dickson_2015). These data indicate that the variant is likely to be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 33098355, 31194252, 26260077, 30442156, 22976768, 32432561, 30093709, 35787971). ClinVar contains an entry for this variant (Variation ID: 567566). Based on the evidence outlined above, the variant was classified as likely pathogenic. - |
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 21, 2024 | This sequence change replaces leucine, which is neutral and non-polar, with proline, which is neutral and non-polar, at codon 526 of the IDUA protein (p.Leu526Pro). This variant is present in population databases (rs781136336, gnomAD 0.07%). This missense change has been observed in individual(s) with mucopolysaccharidosis type I (PMID: 22976768, 30442156; Invitae). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 567566). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on IDUA protein function. For these reasons, this variant has been classified as Pathogenic. - |
not provided Pathogenic:1Uncertain:1
Likely pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Jul 12, 2021 | Observed in apparent homozygous state through newborn screening in an infant with >50% enzymatic activity (Donati et al., 2018); In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; This variant is associated with the following publications: (PMID: 33072983, 32432561, 33147872, 27535533, 30442156, 22976768, 26260077, 30093709) - |
Uncertain significance, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Jan 11, 2024 | - - |
Mucopolysaccharidosis, MPS-I-H/S Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | MGZ Medical Genetics Center | Jan 28, 2022 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at